Pathological precision diagnosis and recent advances in HER2 low and ultralow in breast cancer: a narrative review
Translational Breast Cancer Research · 2024-10 · 5 · 29-29
DOI: 10.21037/tbcr-24-33 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Translational Breast Cancer Research, 2024-10. Verfasst von Jiuyan Shang und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China. Die Arbeit wurde bisher 7-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pathology, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China.
Zitieren
APA
Shang, J., & Liu, Y. (2024). Pathological precision diagnosis and recent advances in HER2 low and ultralow in breast cancer: a narrative review. Translational Breast Cancer Research, 5, 29-29. https://doi.org/10.21037/tbcr-24-33
Vancouver
Shang J, Liu Y. Pathological precision diagnosis and recent advances in HER2 low and ultralow in breast cancer: a narrative review. Translational Breast Cancer Research. 2024;5:29-29. doi:10.21037/tbcr-24-33
BibTeX
@article{Shang2024,
author = {Shang, Jiuyan and Liu, Yueping},
title = {Pathological precision diagnosis and recent advances in HER2 low and ultralow in breast cancer: a narrative review},
journal = {Translational Breast Cancer Research},
year = {2024},
volume = {5},
pages = {29--29},
doi = {10.21037/tbcr-24-33}
}
EUVIMED